ArticleBMC public health2026
Incidence and predictors of diabetic ketoacidosis among adults with type 1 diabetes in Northwest, Ethiopia, 2023: a retrospective cohort study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic ketoacidosis (DKA) is a serious, potentially fatal diabetes complication, particularly in low-resource settings, marked by hyperglycemia, ketoacidosis, and ketonuria. Mortality from DKA remains high in developing countries, including Ethiopia. Despite its impact, data on DKA’s incidence and predictors are limited in Ethiopia.
objectivesTo determine the incidence and predictors of DKA among adults with type 1 diabetes in Amhara regional state hospitals, 2023.
methodsA five-year retrospective cohort study was conducted, analyzing records from September 11, 2017, to September 10, 2022. Data extraction occurred from April 12 to May 28, 2023, using simple random sampling to select 634 participant records. Data were entered and analyzed with EPI data version 4.6.0.6 and STATA version 17.
resultsAmong participants, 240 (39.8%) developed DKA, with an incidence rate of 15.96 per 100 person-years (95% CI: 14.04, 18.12). Significant predictors of DKA included middle age (AHR: 0.35, 95% CI: 0.21, 0.58), sex (AHR: 0.72, 95% CI: 0.55, 0.95), family history of diabetes (AHR: 1.45, 95% CI: 1.01, 2.11), long disease duration (AHR: 13.30, 95% CI: 9.09, 19.46), poor glycemic control (AHR: 2.29, 95% CI: 1.70, 3.08), recent acute illness (AHR: 1.41, 95% CI: 1.06, 1.87), comorbidities (AHR: 1.78, 95% CI: 1.34, 2.38), and medication noncompliance (AHR: 2.35, 95% CI: 1.76, 3.15).
conclusionsDKA incidence remains high in this cohort. Interventions should focus on improving glycemic control, medication compliance, and managing comorbidities to reduce DKA risk. Additionally, education targeting those with long disease duration and a family history of diabetes is recommended to prevent DKA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.